Incyte (INCY) Research & Development (2010 - 2026)
Incyte (INCY) reported Research & Development of $516.95 million for Q2 2026, up 4.5% from $494.92 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Incyte's Research & Development came in at $2.15 billion, up 9.1% year-over-year; for FY2025, it came in at $2.05 billion, down 21.4% from FY2024.
- Research & Development has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- By year, Research & Development came in at $2.61 billion in FY2024 (+60.2%), $1.63 billion in FY2023 (+2.6%), $1.59 billion in FY2022 (+8.8%) and $1.46 billion in FY2021 (-34.2%).
- Five-year quarterly Research & Development spans a low of $334.95 million in Q3 2021 and a high of $1.14 billion in Q2 2024.
- Year over year, Research & Development has now increased in each of the last three quarters, with growth averaging 5.6% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 184.1%); the low point was Q2 2025 (a decline of 56.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $515.9 million (Q1 2026), $611.37 million (Q4 2025) and $506.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 516.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 516.95 Mn |
| Mar 31, 2026 | 515.90 Mn |
| Dec 31, 2025 | 611.37 Mn |
| Sep 30, 2025 | 506.58 Mn |
| Jun 30, 2025 | 494.92 Mn |
| Mar 31, 2025 | 437.28 Mn |
| Dec 31, 2024 | 466.03 Mn |
| Sep 30, 2024 | 573.17 Mn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 429.26 Mn |
| Dec 31, 2023 | 444.49 Mn |
| Sep 30, 2023 | 375.71 Mn |
| Jun 30, 2023 | 400.75 Mn |
| Mar 31, 2023 | 406.64 Mn |
| Dec 31, 2022 | 501.36 Mn |
| Sep 30, 2022 | 384.01 Mn |
| Jun 30, 2022 | 347.20 Mn |
| Mar 31, 2022 | 353.37 Mn |
| Dec 31, 2021 | 472.83 Mn |
| Sep 30, 2021 | 334.95 Mn |
API Access
Incyte Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();